AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $365,000 | +22.9% | 38,800 | 0.0% | 0.04% | +14.7% |
Q2 2020 | $297,000 | +23.8% | 38,800 | 0.0% | 0.03% | 0.0% |
Q1 2020 | $240,000 | -49.2% | 38,800 | 0.0% | 0.03% | -39.3% |
Q4 2019 | $472,000 | +5.4% | 38,800 | 0.0% | 0.06% | +5.7% |
Q3 2019 | $448,000 | +15.5% | 38,800 | 0.0% | 0.05% | +10.4% |
Q2 2019 | $388,000 | -22.4% | 38,800 | 0.0% | 0.05% | -27.3% |
Q1 2019 | $500,000 | -15.1% | 38,800 | 0.0% | 0.07% | -25.0% |
Q4 2018 | $589,000 | -24.1% | 38,800 | 0.0% | 0.09% | -4.3% |
Q3 2018 | $776,000 | -14.6% | 38,800 | -16.7% | 0.09% | +10.8% |
Q2 2018 | $909,000 | -3.2% | 46,600 | 0.0% | 0.08% | -8.8% |
Q1 2018 | $939,000 | +52.2% | 46,600 | 0.0% | 0.09% | +54.2% |
Q4 2017 | $617,000 | -32.6% | 46,600 | -6.0% | 0.06% | -28.0% |
Q3 2017 | $915,000 | +0.3% | 49,600 | 0.0% | 0.08% | -2.4% |
Q2 2017 | $912,000 | -18.4% | 49,600 | 0.0% | 0.08% | -20.0% |
Q1 2017 | $1,118,000 | -16.3% | 49,600 | +29.2% | 0.10% | +54.4% |
Q4 2016 | $1,336,000 | – | 38,400 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 4,060,000 | $46,893,000 | 3.11% |
Camber Capital Management LP | 4,390,000 | $50,705,000 | 2.67% |
Palo Alto Investors LP | 3,078,874 | $35,561,000 | 2.37% |
Permanens Capital L.P. | 407,811 | $4,710,000 | 1.32% |
Fondren Management LP | 35,000 | $404,000 | 0.34% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 33,524 | $387,000 | 0.29% |
BOOTHBAY FUND MANAGEMENT, LLC | 240,000 | $2,772,000 | 0.25% |
Broadfin Capital, LLC | 100,000 | $1,155,000 | 0.21% |
FOX RUN MANAGEMENT, L.L.C. | 13,687 | $158,000 | 0.14% |
Spark Investment Management LLC | 92,200 | $1,064,000 | 0.14% |